Sports

Big blow to Dipa Karmakar, ITA bans him for 21 months for doping

There is bad news for the fans of star gymnast and Khel Ratna awardee Dipa Karmakar. Deepa Karmakar has been banned for 21 months. This ban has been imposed by the International Testing Agency on Deepa as she has been found guilty of taking the banned drug Hygenamine.
 
According to the information, Deepa Karmakar’s samples were taken out of the competition on 11 October 2021. After this, Deepa’s test has come positive in the investigation, due to which she has been found accused of doping. He has been banned by the ITA till July 10, 2023. Please tell that the medicines used by Deepa are prohibited to be used outside or inside the competition.
 
Deepa used them
Testing of Deepa’s samples revealed that she had used Hygemin S3 Beta 2, the use of which is prohibited. The International Doping Agency has placed these medicines in the banned category. If a player is found using these drugs, he is banned.
 
According to the information, this test was done on Deepa in the year 2021. In this regard, the International Doping Agency informed that Deepa has given a positive test in the test. This test was done on October 11, 2021 by the Federation of International Gymnasts, the results of which have come positive. Significantly, after this test, Deepa has not participated in any competition. At the same time, in the year 2018, she had knee surgery, after which she has been recovering continuously.
 
Made India proud in Olympics
Let us tell you that Deepa Karmakar had brought laurels to India in the Rio Olympics held in the year 2016. She was the first gymnast to represent India in the Olympics. Deepa had secured fourth position in Rio Olympics. She was in news even without winning a medal. Earlier in the year 2014, in the Glasgow Commonwealth Games, Deepa had won the bronze medal.

People News Chronicle

People News Chronicle author account is for interns, who are just new to our news agency. They are taught basics of wordpress and publishing through this account.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button